Literature DB >> 3288698

Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin.

J J Wirth1, F Kierszenbaum.   

Abstract

We examined in this work whether rTNF inhibits the capacity of Trypanosoma cruzi to multiply within murine macrophages or enhances the ability of the phagocytic host cells to destroy internalized parasites. We found that rTNF would not alter the fate of the trypanosomes within macrophages over a 48-h incubation period unless the latter cells were also treated with 1 ng/ml bacterial endotoxin (LPS). Treatment of macrophages with rTNF plus LPS, but not separate treatment with either rTNF or LPS, resulted in a significant decrease in the number of organisms per 100 macrophages with respect to values obtained with mock-treated macrophages. In addition, there was a significant reduction in the proportion of infected macrophages over the 48-h incubation period, indicating parasite clearance by the host cells. The combined effects of rTNF and LPS were seen when macrophages from CBA/J were used but not with LPS-insensitive macrophages from C3H/HeJ mice. Increased trypanosome killing by CBA/J macrophages treated with rTNF plus LPS was not seen when catalase was present in the culture medium, indicating a role for hydrogen peroxide in the cytotoxic effect. These results show that rTNF can affect the fate of T. cruzi within macrophages if LPS is present and point to destruction of internalized organisms rather than inhibition of parasite multiplication as the most likely explanation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288698

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Induction of anti-mycobacterial and anti-listerial activity of human monocytes requires different activation signals.

Authors:  G Zerlauth; M M Eibl; J W Mannhalter
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice.

Authors:  E Castaños-Velez; S Maerlan; L M Osorio; F Aberg; P Biberfeld; A Orn; M E Rottenberg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages.

Authors:  A Descoteaux; G Matlashewski
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.

Authors:  J S Silva; G N Vespa; M A Cardoso; J C Aliberti; F Q Cunha
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.

Authors:  W Chen; E A Havell; A G Harmsen
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection.

Authors:  T Laskay; H G Mariam; T Y Berhane; T E Fehniger; R Kiessling
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

10.  Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis.

Authors:  F Y Liew; C Parkinson; S Millott; A Severn; M Carrier
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.